DYNT $1.56
search.messages.yahoo.com
Yahoo! Message Boards - Message Matches (1 - 20 of 34)
Business & Finance > Investments > Sectors > Healthcare > Biotechnology and Drugs > VLTS
wally should pump DYNT - DYNT is light therapy which is a huge new growth area. Marketcap 15 mil and rev 20 mil. - by: timmaetimmae
VLTS - VLTS killed me not so long ago and I am going to make my money back on DYNT. DYNT is into light therapy for asthetics and chronic pain. These are huge growth areas that are in their infancy stage. Market Cap of 13.8 million, revenues of 20 million and profitable. Last fiscal year, that ended a quarter ago, was their best year and due to a slight hickup this year started as their second best year. Huge buying opportunity this stock could go over ten. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Biotechnology and Drugs > ANIK
Keep your eye on DYNT - It should do what ANIK did last year. I saw a few ads for ANIK in my fathers last practice management magazine. DYNT is into light therapy for asthetics and chronic pain. These are huge growth areas that are in their infancy stage. Market Cap of 13.8 million, revenues of 20 million and profitable. Last fiscal year, that ended a quarter ago, was their best year and due to a slight hickup this year started as their second best year. Huge buying opportunity this stock could go over ten. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Biotechnology and Drugs > SONT
Look at DYNT for a better play - They are into light therapy for asthetics and chronic pain. These are huge growth areas that are in their infancy stage. Market Cap of 13.8 million, revenues of 20 million and profitable. Last fiscal year, that ended a quarter ago, was their best year and due to a slight hickup this year started as their second best year. Huge buying opportunity this stock could go over ten. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Medical Equipment and Supplies > RITA
Watch another one DYNT - It is in light and low power laser therapy for pain and asthetics. This is a huge growth area. FLoat is less than 9 million and the company is profitable. Market cap is less than 15 million. CHeck it out and diversify a bit - by: timmaetimmae
Business & Finance > Investments > Sectors > Technology > Software and Programming > BITS
DYNT is about to pop - In light and low power laser therapy for pain and asthetics. This is a huge growth area. FLoat is less than 9 million and the company is profitable. Market cap is less than 15 million. - by: timmaetimmae
NICE MOVE - DYNT should do the same soon. They are into light therapy for asthetics and chronic pain. These are huge growth areas that are in their infancy stage. Market Cap of 13.8 million, revenues of 20 million and profitable. Last fiscal year, that ended a quarter ago, was their best year and due to a slight hickup this year started as their second best year. Huge buying opportunity this stock could go over ten. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Medical Equipment and Supplies > ELOS
Just go and buy DYNT - Go buy DYNT before ELOS does. They already have FDA approval for a asthstic light therapy device Synergie. The Synergie revenues jumped 50% last quarter and the stock is trading at a whopping 13 million market cap with 20 million in revenues. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Medical Equipment and Supplies > ANGN
FUTURE WINNER - Look at DYNT. DYNT is into light therapy for asthetics and chronic pain. These are huge growth areas that are in their infancy stage. Market Cap of 13.8 million, revenues of 20 million and profitable. Last fiscal year, that ended a quarter ago, was their best year and due to a slight hickup this year started as their second best year. Huge buying opportunity this stock could go over ten. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Medical Equipment and Supplies > PMTI
A good future play - DYNT is into light therapy for asthetics and chronic pain. These are huge growth areas that are in their infancy stage. Market Cap of 13.8 million, revenues of 20 million and profitable. Last fiscal year, that ended a quarter ago, was their best year and due to a slight hickup this year started as their second best year. Huge buying opportunity this stock could go over ten. You guys must remember where PMTI used to be. - by: timmaetimmae
Business & Finance > Investments > Sectors > Technology > Semiconductors > TGAL
Re: This stock is so under value - TGAL is undervalued but they need to stop the cash burn before it is really going to shoot up. Take a look at DYNT for a low market cap high growth play that has yet to catch on. It is in light therapy for asthetics and chronic pain. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Biotechnology and Drugs > EBIO
Another opportunity - Check out DYNT. It is into light therapy for chronic pain and asthetics. It should pop soon. Low market cap and earnings. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Biotechnology and Drugs > ISIS
look at another stock - DYNT is into light therapy for chronic pain and asthetics. It should pop soon. Low market cap and earnings. Light therapy is only in its infancy stage of use. It can even be used to repair tissue better after a workout. - by: timmaetimmae
Business & Finance > Investments > Sectors > Technology > Software and Programming > BITS
May - They may have finally got that major wireless deal. Look at DYNT for a future run. THere were three stocks I liked at 1.50 and only one is still there: BITS BRLC DYNT - by: timmaetimmae
BITS - BITS was one of my picks, now buy DYNT. Light therapy is a huge growth area in cosmetics and medicine and DYNT will be a major player. Low 13 mil in float with over 20 mil in revenues. - by: timmaetimmae
Business & Finance > Investments > Sectors > Healthcare > Medical Equipment and Supplies > ELOS
Light Therapy - dynatronics.com Compare some of the products to a company that has a 13 million dollar market cap. DYNT has a very similar product to the one that crushed this stock. - by: timmaetimmae
Re: rediculous reaction - Very Rdiculous: DYNT Dynatronics has a FDA approved product which grew revenues 50% last quarter and its market cap is only 13 million. How can ELOS loose almost 200 million on just a delay. Take a look: dynatronics.com - by: timmaetimmae
Light Therapy - Light therapy is a huge growth area it is only a matter of time before ELOS is approved since DYNT is already in the market. - by: timmaetimmae
Link - dynatronics.com DYNT light therapy for cellulite reduction. - by: timmaetimmae
Business & Finance > Investments > Sectors > Services > Retail (Technology) > HRVE
HRVE - HRVE finally is making its way. DYNT is another of my favorites. It will have its day sometime soon. It is profitable and in the high growth light therapy market for chonic pain and asthetics. Market cap of 13 million and revenues of 20 million. Last year revenues grew at over 20%. Keep your eye on DYNT - by: timmaetimmae
Business & Finance > Investments > Sectors > Technology > Electronic Instruments and Controls > SSPI
Specrum - This company has huge growth potential since RFID is a growth area. Another company DYNT is in the Light therapy market and has a low float. I think you will find that DYNT has great fundamentals. - by: timmaetimmae |
